Why the study?
Obesity increases the risk of hypertension and other cardiometabolic comorbidities, but the lasting effects of lifestyle modifications on weight and BP reduction are limited.
Nurse practitioners are well positioned to manage obesity-related hypertension using lifestyle modifications, medications, and metabolic surgery to improve clinical outcomes.
May support NP-led obesity-hypertension care; leaves open need for prospective trials to confirm outcomes.
Obesity increases the risk of hypertension and other cardiometabolic comorbidities. Lifestyle modifications are usually recommended, though lasting effects on weight and BP reduction are limited. Weight-loss medications, especially incretin mimetics, are effective for short- and long-term treatment. Metabolic surgery provides cure of obesity-related hypertension in some patients. NPs are well positioned to manage obesity-related hypertension to improve clinical outcomes of affected individuals.
No takes yet. Share an insight, caveat, or question.
Benenson et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: